2023 CRISPR-influenced symbiosis. Reysenbach AL, Terns MP.Nat Microbiol. 2023 Aug 14. doi: 10.1038/s41564-023-01445-4. Online ahead of print. Histones direct site-specific CRISPR spacer acquisition in model archaeon. Watts EA, Garrett SC, Catchpole RJ, Clark LM, Sanders TJ, Marshall CJ, Wenck BR, Vickerman RL, Santangelo TJ, Fuchs R, Robb B, Olson S, Graveley BR, Terns MP. Nat Microbiol. 2023 Aug 7. doi: 10.1038/s41564-023-01446-3. Online ahead of print.PMID: 37550505 A self-transmissible plasmid from a hyperthermophile that facilitates genetic modification of diverse Archaea. Catchpole RJ, Barbe V, Magdelenat G, Marguet E, Terns M, Oberto J, Forterre P, Da Cunha V. Nat Microbiol. 2023 Jul;8(7):1339-1347. doi: 10.1038/s41564-023-01387-x. Epub 2023 Jun 5.PMID: 37277532 Investigation of CRISPR-Independent Phage Resistance Mechanisms Reveals a Role for FtsH in Phage Adsorption to Streptococcus thermophilus. Garrett SC, Philippe C, Kim JG, Wei Y, Johnson KA, Olson S, Graveley BR, Terns MP. J Bacteriol. 2023 Jun 27;205(6):e0048222. doi: 10.1128/jb.00482-22. Epub 2023 May 31.PMID: 37255445 2022 Hyper-stimulation of Pyrococcus furiosus CRISPR DNA uptake by a self-transmissible plasmid. Watts EA, Garrett SC, Catchpole RJ, Clark LM, Graveley BR, Terns MP. Extremophiles. 2022 Nov 16;26(3):36. doi: 10.1007/s00792-022-01281-0.PMID: 36385310 Allosteric control of type I-A CRISPR-Cas3 complexes and establishment as effective nucleic acid detection and human genome editing tools. Hu C, Ni D, Nam KH, Majumdar S, McLean J, Stahlberg H, Terns MP, Ke A. Mol Cell. 2022 Aug 4;82(15):2754-2768.e5. doi: 10.1016/j.molcel.2022.06.007. Epub 2022 Jul 13.PMID: 35835111 Type III-A CRISPR systems as a versatile gene knockdown technology. Woodside WT, Vantsev N, Catchpole RJ, Garrett SC, Olson S, Graveley BR, Terns MP. RNA. 2022 Aug;28(8):1074-1088. doi: 10.1261/rna.079206.122. Epub 2022 May 26.PMID: 35618430 Structural and biochemical characterization of in vivo assembled Lactococcus lactis CRISPR-Csm complex. Sridhara S, Rai J, Whyms C, Goswami H, He H, Woodside W, Terns MP, Li H. Commun Biol. 2022 Mar 29;5(1):279. doi: 10.1038/s42003-022-03187-1.PMID: 35351985 Unique properties of spacer acquisition by the type III-A CRISPR-Cas system. Zhang X, Garrett S, Graveley BR, Terns MP. Nucleic Acids Res. 2022 Feb 22;50(3):1562-1582. doi: 10.1093/nar/gkab1193.PMID: 34893878 2021 New Type III CRISPR variant and programmable RNA targeting tool: Oh, thank heaven for Cas7-11. Catchpole RJ, Terns MP. Mol Cell. 2021 Nov 4;81(21):4354-4356. doi: 10.1016/j.molcel.2021.10.014.PMID: 34739827 2020 Primed CRISPR DNA uptake in Pyrococcus furiosus. Garrett S, Shiimori M, Watts EA, Clark L, Graveley BR, Terns MP. Nucleic Acids Res. 2020 Jun 19;48(11):6120-6135. doi: 10.1093/nar/gkaa381.PMID: 32421777 Regulation of the RNA and DNA nuclease activities required for Pyrococcus furiosus Type III-B CRISPR-Cas immunity. Foster K, Grüschow S, Bailey S, White MF, Terns MP. Nucleic Acids Res. 2020 May 7;48(8):4418-4434. doi: 10.1093/nar/gkaa176.PMID: 32198888 Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Makarova KS, Wolf YI, Iranzo J, Shmakov SA, Alkhnbashi OS, Brouns SJJ, Charpentier E, Cheng D, Haft DH, Horvath P, Moineau S, Mojica FJM, Scott D, Shah SA, Siksnys V, Terns MP, Venclovas Č, White MF, Yakunin AF, Yan W, Zhang F, Garrett RA, Backofen R, van der Oost J, Barrangou R, Koonin EV. Nat Rev Microbiol. 2020 Feb;18(2):67-83. doi: 10.1038/s41579-019-0299-x. Epub 2019 Dec 19.PMID: 31857715 A journey down to hell: new thermostable protein-tags for biotechnology at high temperatures. Mattossovich R, Merlo R, Fontana A, d'Ippolito G, Terns MP, Watts EA, Valenti A, Perugino G. Extremophiles. 2020 Jan;24(1):81-91. doi: 10.1007/s00792-019-01134-3. Epub 2019 Sep 25.PMID: 31555904 For older articles, please see either: Google Scholar page for Michael Terns or Pubmed search for Michael Terns
